F R Appelbaum, C D Buckner. Show Affiliations »
Abstract
Mesh: See more » AnimalsAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useBone Marrow TransplantationCarmustine/administration & dosageCarmustine/therapeutic useClinical Trials as TopicCombined Modality TherapyCyclophosphamide/administration & dosageCyclophosphamide/therapeutic useCytarabine/therapeutic useDrug EvaluationDrug ResistanceEtoposide/administration & dosageHodgkin Disease/drug therapyHodgkin Disease/radiotherapyHodgkin Disease/therapyHumansLeukemia/therapyLeukemia, Lymphoid/therapyLymphoma/drug therapyLymphoma/radiotherapyLymphoma/therapyMelphalan/administration & dosageNeoplasm Recurrence, Local/therapyNeoplasms/drug therapyNeoplasms/radiotherapyNeoplasms/therapyThioguanine/therapeutic useTransplantation, Autologous
Substances: See more » Antineoplastic AgentsCytarabineEtoposideCyclophosphamideThioguanineMelphalanCarmustine
Year: 1986 PMID: 3516484 DOI: 10.1016/s0308-2261(86)80003-0
Source DB: PubMed Journal: Clin Haematol ISSN: 0308-2261